Effects of aging on clinical outcomes in patients receiving genotype ‐guided P2Y12 inhibitor selection after percutaneous coronary intervention

ConclusionThis study suggests important clinical benefits ofCYP2C19 genotype-guided antiplatelet therapy after PCI in both younger and older patients.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - July 21, 2021 Category: Drugs & Pharmacology Authors: Brian Wood, Craig R. Lee, Ian R. Mulrenin, Megan N. Gower, Joseph S. Rossi, Karen E. Weck, George A. Stouffer Tags: TI on Advances in Cardiovascular Pharmacotherapy Source Type: research